SMS Pharmaceuticals posts Q1FY23 consolidated loss at Rs. 12.76 Cr
News

SMS Pharmaceuticals posts Q1FY23 consolidated loss at Rs. 12.76 Cr

The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022.

  • By IPP Bureau | August 14, 2022

SMS Pharmaceuticals Limited has posted net loss of Rs. 12.76 crores for the period ended June 30, 2022 as against net profit of Rs. 6.17 crores for the period ended March 31, 2022. The company posted net profit of Rs.23.56 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022 as compared to Rs. 61.3454 crores during the period ended March 31, 2022. It reported total income of Rs.164.28 crores during the period ended June 30, 2021.

Upcoming E-conference

Other Related stories

Startup

Digitization